Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationTransplantation ConditioningMultiple MyelomaBone MarrowAntineoplastic Combined Chemotherapy ProtocolsMelphalanCombined Modality TherapyGranulocyte Colony-Stimulating FactorTreatment OutcomeBone Marrow CellsRemission InductionAntigens, CD34Stem CellsSalvage TherapyDisease-Free SurvivalCyclophosphamideGraft vs Host DiseaseEtoposideLiver TransplantationRecurrenceHematopoietic Stem Cell MobilizationHodgkin DiseaseLymphoma, Non-HodgkinBone Marrow PurgingCytarabineMyeloablative AgonistsHematopoietic Stem CellsSurvival RateCarmustineHematologic NeoplasmsWhole-Body IrradiationGraft SurvivalSurvival AnalysisThiotepaVincristineRetrospective StudiesBusulfanKidney TransplantationLymphoma, Mantle-CellPrognosisAmyloidosisDoxorubicinBone and BonesFollow-Up StudiesTime FactorsTransplantation ChimeraDexamethasoneBoronic AcidsTissue DonorsPyrazinesMesenchymal Stem Cell TransplantationAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedLeukapheresisLymphoma, FollicularLymphoma, T-Cell, PeripheralAntineoplastic AgentsAutograftsCell TransplantationIfosfamideLymphomaThalidomideCord Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteHeart TransplantationPrednisoneNeoplasm, ResidualInduction ChemotherapyPodophyllotoxinImmunosuppressive AgentsLung TransplantationHematopoiesisCell DifferentiationMyelodysplastic SyndromesLymphoma, Large B-Cell, DiffuseHistocompatibility TestingMaintenance ChemotherapyLeukemiaBlood Component RemovalGraft RejectionTransplantation ImmunologyHistocompatibilityProspective StudiesLymphoma, B-CellBone Marrow DiseasesOrgan TransplantationAntibodies, MonoclonalEmbryonic Stem CellsLeukemia, MyeloidMitoxantroneIdarubicinCells, CulturedNeoplasms, Second PrimaryLeukemia, Plasma CellEnteropathy-Associated T-Cell Lymphoma